Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no changes to study details, eligibility criteria, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Texas listing under a new Locations section and removed the old 'Texas Locations' label to clarify site listings.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page shows a minor site revision update: the addition of 'Revision: v3.3.2' and the removal of the previous 'Revision: v3.2.0', which does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page no longer displays a site-wide notice about government funding and NIH operating status, which is a non-critical, general status message not affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe screenshots show a rearranged layout and updated UI elements on the study details page without changes to key trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check104 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference4%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.